Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-07-02

Clinical Trial Update: Aprepitant's Effect on Drug Metabolism in Multi-Day Combination (CHOP/R-CHOP) Chemotherapy Regimen in Lymphoma Patients [NA]

View source ↗

Summary

This study examined the effect of aprepitant on drug metabolism when given with multi-day CHOP/R-CHOP chemotherapy in lymphoma patients; results have been poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EMEND (aprepitant)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Lymphoma | NA | Status: COMPLETED | Results posted: 2013-07-02